These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30183614)

  • 1. Blood safety policy: should cautionary policies be adopted with caution?
    Riva L; Petrini C
    Blood Transfus; 2018 Sep; 16(5):405-407. PubMed ID: 30183614
    [No Abstract]   [Full Text] [Related]  

  • 2. Moving on from voluntary non-remunerated donors: who is the best blood donor?
    Allain JP
    Br J Haematol; 2011 Sep; 154(6):763-9. PubMed ID: 21539535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technological evolutions in blood donation screening and their impact on the residual risk].
    Barlet V
    Transfus Clin Biol; 2011 Apr; 18(2):292-301. PubMed ID: 21466969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans people and blood donation.
    Goldman M; Butler-Foster T; Lapierre D; O'Brien SF; Devor A
    Transfusion; 2020 May; 60(5):1084-1092. PubMed ID: 32343438
    [No Abstract]   [Full Text] [Related]  

  • 5. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors.
    Slot E; Janssen MP; Marijt-van der Kreek T; Zaaijer HL; van de Laar TJ
    Transfusion; 2016 Jan; 56(1):203-14. PubMed ID: 26355711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood donor hemovigilance: impact for donor and recipient safety].
    Hauser L; Beyloune A; Simonet M; Bierling P
    Transfus Clin Biol; 2013 May; 20(2):99-103. PubMed ID: 23587614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7th International Association of Biological Standardization (IABS) Symposium on Advances in Transfusion Safety.
    Teo D
    Biologicals; 2012 May; 40(3):169. PubMed ID: 22507451
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug use in blood donors].
    Berg JA; Schjøtt J
    Tidsskr Nor Laegeforen; 2016 May; 136(8):718-20. PubMed ID: 27143462
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood safety in Mexico. Achievements and challenges].
    Sánchez-Guerrero SA
    Rev Invest Clin; 2011; 63(3):309-13. PubMed ID: 21888294
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of donor selection on blood safety in Iran.
    Razjou F; Maghsudlu M; Nasizadeh S; Zadsar M
    Transfus Apher Sci; 2012 Aug; 47(1):13-6. PubMed ID: 22521567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries.
    O'Brien SF; Delage G; Seed CR; Pillonel J; Fabra CC; Davison K; Kitchen A; Steele WR; Leiby DA
    Transfus Med Rev; 2015 Jul; 29(3):162-71. PubMed ID: 25933591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood donation in China: sustaining efforts and challenges in achieving safety and availability.
    Yin YH; Li CQ; Liu Z
    Transfusion; 2015 Oct; 55(10):2523-30. PubMed ID: 26111254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors.
    Busch MP
    Transfusion; 2006 Oct; 46(10):1663-6. PubMed ID: 17002621
    [No Abstract]   [Full Text] [Related]  

  • 14. The History and Challenges of Blood Donor Screening in China.
    Li L; Li KY; Yan K; Ou G; Li W; Wang J; Song N; Tian L; Ji X; Chen Y; Liang X; Liu Z; Wu Y
    Transfus Med Rev; 2017 Apr; 31(2):89-93. PubMed ID: 28012709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood transfusion and supply chain management safety].
    Quaranta JF; Caldani C; Cabaud JJ; Chavarin P; Rochette-Eribon S
    Presse Med; 2015 Feb; 44(2):214-20. PubMed ID: 25578550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Context and social perceptions of blood donation in donors found positive for human immunodeficiency virus in France.
    Duquesnoy A; Danic B; Santos A; Martinaud C; Woimant G; Laperche S; Tiberghien P; Jauffret-Roustide M; Pillonel J;
    Transfusion; 2017 Sep; 57(9):2240-2247. PubMed ID: 28671313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood donations: justifying blood donor restrictions.
    Spence JN; Iqbal FM
    Br J Haematol; 2016 Sep; 174(5):822-3. PubMed ID: 26492347
    [No Abstract]   [Full Text] [Related]  

  • 18. The yield of temporary exclusion of blood donors, exposed to emerging infections abroad.
    Lieshout-Krikke RW; Zaaijer HL; Prinsze FJ
    Vox Sang; 2013 Jan; 104(1):12-8. PubMed ID: 22775433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who should donate blood? Policy decisions on donor deferral criteria should protect recipients and be fair to donors.
    Brailsford SR; Kelly D; Kohli H; Slowther A; Watkins NA;
    Transfus Med; 2015 Aug; 25(4):234-8. PubMed ID: 26190553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
    Dodd RY; Nguyen ML; Krysztof DE; Notari EP; Stramer SL
    Transfusion; 2018 Sep; 58(9):2166-2170. PubMed ID: 30144082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.